Search -

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Conference News TCT 2016

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

Shelley Wood

November 07, 2016

Presentation TCT 2016

Stent Design and Comprehensive Data Review: Orsiro Cobalt Chromium Sirolimus-Eluting Stents

Presenter: Dean J. Kereiakes, Pieter C. Smits, Thomas Pilgrim

October 30, 2016

News Conference News TCT 2016

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Todd Neale

October 30, 2016

Presentation TCT 2015

Device and Clinical Program Highlights: Orsiro

Presenter: Pieter C. Smits, Philip M. Urban, Thomas Pilgrim

October 12, 2015

Presentation TCT 2014

BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) ? 2 Year___

Presenter: Rafael Ruiz-Salmeron

September 16, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms II: ORSIRO

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Stephan Windecker

September 15, 2014

Presentation TCT 2013

TCT-69. Safety and clinical performance of the drug eluting Orsiro stent in patients with single de novo coronary artery lesions – II (BIOFLOW-II) -A quantitative analysis by IV...

Presenter: Thierry Lefevre

October 29, 2013

Presentation TCT 2013

Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)

Presenter: Stephan Windecker

October 29, 2013

Presentation TCT 2012

Orsiro (BIOTRONIK) Program Update

Presenter: Stephan Windecker

October 23, 2012

Advertisement

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

Stent Design and Comprehensive Data Review: Orsiro Cobalt Chromium Sirolimus-Eluting Stents

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Device and Clinical Program Highlights: Orsiro

BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) ? 2 Year___

Cobalt-Chromium Sirolimus-Eluting Platforms II: ORSIRO

TCT-69. Safety and clinical performance of the drug eluting Orsiro stent in patients with single de novo coronary artery lesions – II (BIOFLOW-II) -A quantitative analysis by IV...

Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)

Orsiro (BIOTRONIK) Program Update

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content